Literature DB >> 1958169

Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?

P A Martorana, W Linz, B A Schölkens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1958169     DOI： 10.1007/bf02191526

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN： 0300-8428            Impact factor:   17.165


× No keyword cloud information.
  22 in total

1.  Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors:  H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal:  N Engl J Med       Date:  1972-03-02       Impact factor: 91.245

Review 2.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

3.  Endothelium-derived relaxant factor inhibits platelet activation.

Authors:  R Busse; A Lückhoff; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

4.  The effects of cyclic AMP and cyclic GMP on redox state and energy state in hypoxic rat atria.

Authors:  P Vuorinen; K Laustiola; T Metsä-Ketelä
Journal:  Life Sci       Date:  1984-07-09       Impact factor: 5.037

5.  Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.

Authors:  G Ertl; R A Kloner; R W Alexander; E Braunwald
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

6.  Changes in components of kinin system and hemodynamics in acute myocardial infarction.

Authors:  K Hashimoto; H Hamamoto; Y Honda; M Hirose; S Furukawa; E Kimura
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

Review 7.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

8.  [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].

Authors:  B F Becker; N Reinholz; B Leipert; P Raschke; E Gerlach
Journal:  Klin Wochenschr       Date:  1991

9.  Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.

Authors:  B A Schölkens; W Linz; W König
Journal:  J Hypertens Suppl       Date:  1988-12

10.  [Anti-ischemia effect of enalapril in coronary heart disease. A randomized placebo-controlled double-blind study].

Authors:  N Rietbrock; P Thürmann; R Kirsten; W Schneider
Journal:  Dtsch Med Wochenschr       Date:  1988-02-26       Impact factor: 0.628
View more
  4 in total

1.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?

Authors:  J F Smits; M J Daemen
Journal:  Br Heart J       Date:  1994-09

3.  Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction.

Authors:  N Khaper; K Kaur; T Li; F Farahmand; P K Singal
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

4.  Ramiprilat increases bradykinin outflow from isolated hearts of rat.

Authors:  C R Baumgarten; W Linz; G Kunkel; B A Schölkens; G Wiemer
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.